THE Therapeutic Goods Administration has posted an Australian Public Assessment Report (AusPAR) for Aspens's generic voriconizole, marketed as Vorcon in both oral and IV forms and approved for certain fungal infections - see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Aug 17